Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support

Inmaculada Alía, Miguel A. De La Cal, Andrés Esteban, Ana Abella, Ricard Ferrer, Francisco J. Molina, Antoni Torres, Federico Gordo, José J. Elizalde, Raúl De Pablo, Alejandro Huete, Antonio Anzueto

Producción científica: Contribución a una revistaArtículo en revista científica indexadarevisión exhaustiva

79 Citas (Scopus)

Resumen

Background: Randomized trials assessing the effect of systemic corticosteroids on chronic obstructive pulmonary disease (COPD) exacerbations excluded patients who were mechanically ventilated or admitted to the intensive care unit (ICU). Critically ill patients constitute a population of persons who are prone to develop complications that are potentially associated with the use of corticosteroids (eg, infections, hyperglycemia, ICU-acquired paresis) that could prolong the duration of mechanical ventilation and even increase mortality. Methods: A double-blind placebo-controlled trial was conducted to evaluate the efficacy and safety of systemic corticosteroid treatment in patients with an exacerbation of COPD who were receiving ventilatory support (invasive or noninvasive mechanical ventilation). A total of 354 adult patients who were admitted to the ICUs of 8 hospitals in 4 countries from July 2005 through July 2009 were screened, and 83 were randomized to receive intravenous methylprednisolone (0.5 mg/kg every 6 hours for 72 hours, 0.5 mg/kg every 12 hours on days 4 through 6, and 0.5 mg/kg/d on days 7 through 10) or placebo. The main outcome measures were duration of mechanical ventilation, length of ICU stay, and need for intubation in patients treated with noninvasive mechanical ventilation. Results: There were no significant differences between the groups in demographics, severity of illness, reasons for COPD exacerbation, gas exchange variables, and corticosteroid rescue treatment. Corticosteroid treatment was associated with a significant reduction in the median duration of mechanical ventilation (3 days vs 4 days; P=.04), a trend toward a shorter median length of ICU stay (6 days vs 7 days; P=.09), and significant reduction in the rate of NIV failure (0% vs 37%; P=.04). Conclusion: Systemic corticosteroid therapy in patients withCOPDexacerbations requiring mechanical ventilation is associated with a significant increase in the success of noninvasive mechanical ventilation and a reduction in the duration of mechanical ventilation Trial Registration: clinicaltrials.gov Identifier: NCT01281748.

Idioma originalInglés
Páginas (desde-hasta)1939-1946
Número de páginas8
PublicaciónArchives of Internal Medicine
Volumen171
N.º21
DOI
EstadoPublicada - 28 nov. 2011
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support'. En conjunto forman una huella única.

Citar esto